Table 4.
Multiple Linear Regression Analysis of Factors Associated with Total FIM Score at Discharge in Patients Aged ≥65 Years.
| Variable | B | SE | 95% CI | p Value |
|---|---|---|---|---|
| Age, years | −0.03 | 0.16 | −0.34 to 0.28 | 0.850 |
| Sex: female | −2.02 | 2.35 | −6.66 to 2.61 | 0.391 |
| BMI, kg/m2 | 0.41 | 0.33 | −0.24 to 1.06 | 0.213 |
| Charlson Comorbidity Index | −0.42 | 0.78 | −1.96 to 1.13 | 0.596 |
| Stroke type: hemorrhagic stroke | −4.38 | 3.03 | −10.36 to 1.60 | 0.150 |
| Pre-stroke mRS: 3-4 | −7.45 | 2.89 | −13.14 to −1.76 | 0.011 |
| NIHSS at admission | −0.37 | 0.16 | −0.68 to −0.05 | 0.022 |
| Serum albumin at admission, g/dL | 2.77 | 2.47 | −2.11 to 7.65 | 0.265 |
| Admission motor FIM score | 0.68 | 0.08 | 0.53 to 0.83 | <0.001 |
| Admission cognitive FIM score | 1.57 | 0.16 | 1.26 to 1.88 | <0.001 |
| Pre-admission polypharmacy | −5.25 | 2.49 | −10.16 to −0.33 | 0.037 |
Multivariable linear regression analysis was performed with total FIM score at discharge as the dependent variable in patients aged ≥65 years. The same covariates as in Table 2 were included in the model. All variables were entered simultaneously using the forced-entry method. B indicates the unstandardized regression coefficient. Pre-admission polypharmacy was defined as the use of five or more regular pre-admission medications. The reference categories were male sex, ischemic stroke, pre-stroke mRS 0-2, and non-polypharmacy.
BMI: body mass index; CI: confidence interval; FIM: Functional Independence Measure; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; SE: standard error.